Ulf Bremberg
Technik-/Wissenschafts-/F&E-Leiter bei Beactica Therapeutics AB
Profil
Ulf Bremberg is a Chief Scientific Officer at Beactica Therapeutics AB since 2015.
He previously worked as a Medicinal Chemist at Pharmacia AB, Chemistry Team Leader at Biovitrum AB, Head-Lead Identification Facility at Science for Life Laboratory, and Chief Scientific Officer at OnTarget Chemistry AB.
Dr. Bremberg holds a doctorate degree from the Royal Institute of Technology.
Aktive Positionen von Ulf Bremberg
Unternehmen | Position | Beginn |
---|---|---|
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 |
Ehemalige bekannte Positionen von Ulf Bremberg
Unternehmen | Position | Ende |
---|---|---|
Pharmacia AB | Corporate Officer/Principal | - |
OnTarget Chemistry AB
OnTarget Chemistry AB BiotechnologyHealth Technology Part of Recipharm AB, OnTarget Chemistry AB provides research services for medicinal synthesis and pharmaceutical products. The company is based in Uppsala, Sweden. OnTarget Chemistry was acquired by Recipharm AB on June 15, 2015 for $1.85 million. | Technik-/Wissenschafts-/F&E-Leiter | - |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | - |
Science for Life Laboratory
Science for Life Laboratory Miscellaneous Commercial ServicesCommercial Services Science for Life Laboratory, also known as scilifelab, is a national resource in Sweden that provides unique technologies and expertise to life scientists. The private company is based in Solna, Sweden. The Swedish company is closely connected to a community of researchers in various fields such as biomedicine, ecology, and evolution. | Corporate Officer/Principal | - |
Ausbildung von Ulf Bremberg
Royal Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Distribution Services |
Science for Life Laboratory
Science for Life Laboratory Miscellaneous Commercial ServicesCommercial Services Science for Life Laboratory, also known as scilifelab, is a national resource in Sweden that provides unique technologies and expertise to life scientists. The private company is based in Solna, Sweden. The Swedish company is closely connected to a community of researchers in various fields such as biomedicine, ecology, and evolution. | Commercial Services |
OnTarget Chemistry AB
OnTarget Chemistry AB BiotechnologyHealth Technology Part of Recipharm AB, OnTarget Chemistry AB provides research services for medicinal synthesis and pharmaceutical products. The company is based in Uppsala, Sweden. OnTarget Chemistry was acquired by Recipharm AB on June 15, 2015 for $1.85 million. | Health Technology |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
Pharmacia AB | Health Technology |